240 related articles for article (PubMed ID: 26132489)
1. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
[TBL] [Abstract][Full Text] [Related]
4. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
5. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
[TBL] [Abstract][Full Text] [Related]
7. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.
Chenoweth MJ; Schnoll RA; Novalen M; Hawk LW; George TP; Cinciripini PM; Lerman C; Tyndale RF
Nicotine Tob Res; 2016 Apr; 18(4):491-5. PubMed ID: 26069034
[TBL] [Abstract][Full Text] [Related]
8. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.
Tanner JA; Zhu AZ; Claw KG; Prasad B; Korchina V; Hu J; Doddapaneni H; Muzny DM; Schuetz EG; Lerman C; Thummel KE; Scherer SE; Tyndale RF
Pharmacogenet Genomics; 2018 Jan; 28(1):7-16. PubMed ID: 29232328
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity.
El-Boraie A; Taghavi T; Chenoweth MJ; Fukunaga K; Mushiroda T; Kubo M; Lerman C; Nollen NL; Benowitz NL; Tyndale RF
Addict Biol; 2020 Jan; 25(1):e12741. PubMed ID: 30815984
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
[TBL] [Abstract][Full Text] [Related]
13. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
Chenoweth MJ; Novalen M; Hawk LW; Schnoll RA; George TP; Cinciripini PM; Lerman C; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1773-82. PubMed ID: 25012994
[TBL] [Abstract][Full Text] [Related]
14. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
[TBL] [Abstract][Full Text] [Related]
15. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
Bloom AJ; Harari O; Martinez M; Madden PA; Martin NG; Montgomery GW; Rice JP; Murphy SE; Bierut LJ; Goate A
Hum Mol Genet; 2012 Jul; 21(13):3050-62. PubMed ID: 22451501
[TBL] [Abstract][Full Text] [Related]
16. Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.
Bloom AJ; Baker TB; Chen LS; Breslau N; Hatsukami D; Bierut LJ; Goate A
Hum Mol Genet; 2014 Jan; 23(2):555-61. PubMed ID: 24045616
[TBL] [Abstract][Full Text] [Related]
17. SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers.
Hubacek JA; Kurcova I; Maresova V; Pankova A; Stepankova L; Zvolska K; Lanska V; Kralikova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):84-89. PubMed ID: 31796940
[TBL] [Abstract][Full Text] [Related]
18. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
19. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
